Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01544010 · ClinicalTrials.gov registry record · NA
Optimal TTM Tailoring for Population Cessation
A NA study, sponsored by University of Rhode Island.
- Completed
- Registry status
- NA
- Development phase
- 3,006
- Enrollment target
NCT01544010 is a NA study that has completed, run by University of Rhode Island. The registered enrollment target is 3,006 participants.
The verdict
NCT01544010, a NA study, has completed, sponsored by University of Rhode Island.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,006 participants
- Enrollment target
Study Summary
This study explored optimal tailoring strategies for population tobacco cessation in 4 treatment groups and a control group over 24 months. Transtheoretical model (TTM) tailored feedback on all 14 variables has been found to be a robust population cessation strategy across studies. This proposal sought to find a subset of these variables that is optimal for tailoring, both minimizing response burden while maximizing effectiveness. Addiction variables have been demonstrated to predict smoking outcomes across studies as well, so we will integrate tailored feedback using TTM and addiction variables into an enhanced tailoring group. Optimally tailored feedback that both helps unmotivated smokers reduce their addiction and helps motivated smokers quit could lead to a breakthrough in population cessation.
Interventions
- BEHAVIORAL Stage-Tailored Manual
- BEHAVIORAL Stage Tailored Feedback Report
- BEHAVIORAL Moderate TTM-Tailored Feedback Report
- BEHAVIORAL Full TTM-Tailored Feedback Report
- BEHAVIORAL Enhanced TTM+Addiction Tailored Feedback Report
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,006 participants |
| Start Date | 2009-02 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01544010
The ClinicalTrials.gov registry entry for NCT01544010 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,006 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rhode Island, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Stage-Tailored Manual is the first listed.
NCT01544010 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01544010 about?
NCT01544010 is a clinical study titled "Optimal TTM Tailoring for Population Cessation". This study explored optimal tailoring strategies for population tobacco cessation in 4 treatment groups and a control group over 24 months. Transtheoretical model (TTM) tailored feedback on all 14 variables has been found to be a robust population cessation strategy across studies. This proposal sou...
What is the current status of trial NCT01544010?
This trial is currently completed. It is a NA study. The enrollment target is 3,006 participants. The study started on 2009-02. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01544010?
The interventions under investigation include: Stage-Tailored Manual (BEHAVIORAL), Stage Tailored Feedback Report (BEHAVIORAL), Moderate TTM-Tailored Feedback Report (BEHAVIORAL), Full TTM-Tailored Feedback Report (BEHAVIORAL), Enhanced TTM+Addiction Tailored Feedback Report (BEHAVIORAL).
Who is sponsoring clinical trial NCT01544010?
This trial is sponsored by University of Rhode Island, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.